| P2093 | author name string | A Thomas | |
| | D D Mitsikostas | |
| | M Vikelis | |
| | G Georgiadis | |
| | A Kodounis | |
| | D Zaglis | |
| | M Xifaras | |
| | S Charmoussi | |
| | S Doitsini | |
| P2860 | cites work | Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences | Q42280369 |
| | Prevalence and impact of migraine and probable migraine in a health plan | Q46326510 |
| | Impact of oral dexamethasone versus placebo after ED treatment of migraine with phenothiazines on the rate of recurrent headache: a randomised controlled trial. | Q46835088 |
| | Rizatriptan has central antinociceptive effects against durally evoked responses | Q48685056 |
| | Drug abuse in migraine patients. | Q50588197 |
| | Oral sumatriptan in acute migraine | Q58619528 |
| | A rating scale for depression | Q24564540 |
| | The assessment of anxiety states by rating | Q29614719 |
| | Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy | Q34127399 |
| | Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials | Q34154647 |
| | Patient treatment preferences and the 5-HT1B/1D agonists | Q34445787 |
| | Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors | Q35026810 |
| | Tolerability of the triptans: clinical implications | Q35048015 |
| | Psychiatric comorbidity in migraine: a review | Q36028887 |
| | The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache | Q36905403 |
| | Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours | Q39388130 |
| | Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. | Q39461967 |
| | Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients | Q39464740 |
| | Pain perception in psychiatric disorders: a review of the literature | Q40635943 |
| | Comorbidity of migraine and psychiatric disorders | Q40905718 |
| | Drug-induced headache | Q41676441 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 690-695 | |
| P577 | publication date | 2010-05-06 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial | |
| P478 | volume | 30 | |